The U.S. Food and Drug Administration rebuked 17 companies against selling unapproved products which claim to treat Alzheimer’s disease and other serious ailments.

Authorities from a record 123 countries, including the U.S. FDA, have taken action against hundreds of businesses suspected of illegally selling medicines over the internet, officials said.